Astera Labs (NASDAQ:ALAB) Director Sells 8,994 Shares of Stock

Key Points

• Director Stefan Dyckerhoff sold 8,994 Astera Labs shares for approximately $2.47 million at an average price of $274.96, reducing his direct holdings by 73.1% to 3,309 shares. The transaction was conducted under a pre-arranged Rule 10b5-1 plan.
• Astera Labs recently reported strong quarterly results, with earnings of $0.80 per share and revenue of $392.4 million—beating estimates and representing 104.5% year-over-year growth. The stock traded up 3.2% to $282.82, though it remains well below its 12-month high of $499.48.
• Analyst sentiment remains positive, with a consensus “Moderate Buy” rating and an average price target of $348.33; institutional investors and hedge funds own 60.47% of the company.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) Director Stefan Dyckerhoff sold 8,994 shares of the stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $274.96, for a total value of $2,472,990.24. Following the completion of the transaction, the director directly owned 3,309 shares in the company, valued at approximately $909,842.64. This trade represents a 73.10% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs Trading Up 3.2%

Shares of NASDAQ:ALAB traded up $8.69 during midday trading on Thursday, hitting $282.82. The company had a trading volume of 2,787,635 shares, compared to its average volume of 3,350,008. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48. The firm has a fifty day simple moving average of $332.37 and a 200 day simple moving average of $253.97. The stock has a market cap of $49.07 billion, a price-to-earnings ratio of 176.86 and a beta of 3.77.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same quarter in the prior year, the company posted $0.44 earnings per share. The firm's revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Hedge Funds Weigh In On Astera Labs

Several institutional investors and hedge funds have recently modified their holdings of the business. Keating Financial Advisory Services Inc. bought a new position in Astera Labs in the second quarter valued at approximately $25,000. Archer Investment Corp acquired a new position in shares of Astera Labs in the second quarter valued at approximately $30,000. Transamerica Financial Advisors LLC bought a new stake in shares of Astera Labs during the second quarter worth $35,000. Continuum Advisory LLC bought a new stake in shares of Astera Labs during the second quarter worth $37,000. Finally, Johnson Financial Group Inc. acquired a new stake in shares of Astera Labs during the second quarter worth $43,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Northland Securities raised shares of Astera Labs from a "market perform" rating to an "outperform" rating and set a $350.00 price objective on the stock in a research note on Monday, August 17th. Citigroup reaffirmed a "buy" rating on shares of Astera Labs in a research note on Wednesday, July 29th. Weiss Ratings reiterated a "hold (c)" rating on shares of Astera Labs in a report on Tuesday, August 18th. Morgan Stanley lifted their price target on shares of Astera Labs to $335.00 and gave the stock an "overweight" rating in a research report on Monday, August 3rd. Finally, Jefferies Financial Group boosted their price target on shares of Astera Labs from $270.00 to $450.00 and gave the company a "buy" rating in a report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $348.33.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.